Assignee
DECIPHERA PHARMACEUTICALS LLC
US·81 granted patents·49 pending applications·2,005 citations·filing 2003–2025
Top patents by PatentIndex Score
130 records- 0198US11813251B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Nov 14, 2023·15 cites·4 claims
- 0298US11793795B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Oct 24, 2023·13 cites·10 claims
- 0398US11612591B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Mar 28, 2023·31 cites·11 claims
- 0498US11576903B2Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Feb 14, 2023·31 cites·12 claims
- 0598US11576904B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Feb 14, 2023·33 cites·1 claims
- 0698US11534432B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Dec 27, 2022·34 cites·4 claims
- 0798US11529336B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Dec 20, 2022·31 cites·2 claims
- 0898US11433056B1Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Sep 6, 2022·31 cites·3 claims
- 0998US11426390B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Aug 30, 2022·36 cites·6 claims
- 1098US11395818B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Jul 26, 2022·36 cites·3 claims
- 1198US11344536B1Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted May 31, 2022·37 cites·3 claims
- 1298US11266635B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Mar 8, 2022·39 cites·3 claims
- 1398US11185535B2Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Nov 30, 2021·39 cites·1 claims
- 1498USRE48731EDihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseasesDECIPHERA PHARMACEUTICALS LLC·Filed 2019·Granted Sep 14, 2021·36 cites·21 claims
- 1598US10966966B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Apr 6, 2021·46 cites·3 claims
- 1698US9012635B2Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Apr 21, 2015·61 cites·34 claims
- 1798US7666895B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2006·Granted Feb 23, 2010·85 cites·8 claims
- 1898US7531566B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2006·Granted May 12, 2009·77 cites·8 claims
- 1998US7342037B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2006·Granted Mar 11, 2008·81 cites·13 claims
- 2098US7144911B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2003·Granted Dec 5, 2006·127 cites·8 claims
- 2197US11801237B2Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Oct 31, 2023·13 cites·2 claims
- 2297US11779572B1Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Oct 10, 2023·14 cites·5 claims
- 2397US11590134B2Aminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Feb 28, 2023·19 cites·20 claims
- 2497US11530206B2Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 20, 2022·20 cites·37 claims
- 2597US11518758B2Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 6, 2022·16 cites·20 claims
- 2697US9387202B2Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Jul 12, 2016·60 cites·2 claims
- 2797US9309224B2N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Apr 12, 2016·60 cites·40 claims
- 2897US9187474B2Raf inhibitor compoundsDECIPHERA PHARMACEUTICALS LLC·Filed 2013·Granted Nov 17, 2015·60 cites·19 claims
- 2997US7897762B2Kinase inhibitors useful for the treatment of proliferative diseasesDECIPHERA PHARMACEUTICALS LLC·Filed 2007·Granted Mar 1, 2011·59 cites·93 claims
- 3097US7790756B2Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseasesDECIPHERA PHARMACEUTICALS LLC·Filed 2007·Granted Sep 7, 2010·79 cites·22 claims
- 3197US7737283B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2006·Granted Jun 15, 2010·63 cites·10 claims
- 3297US7202257B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2004·Granted Apr 10, 2007·107 cites·3 claims
- 3396US12285430B2Methods of treating disorders using CSF1R inhibitorsDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Apr 29, 2025·4 cites·18 claims
- 3496US11679110B2Methods of treating disorders using CSF1R inhibitorsDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Jun 20, 2023·24 cites·18 claims
- 3596US11103507B2Methods of treating disorders using CSF1R inhibitorsDECIPHERA PHARMACEUTICALS LLC·Filed 2019·Granted Aug 31, 2021·48 cites·30 claims
- 3696US9193719B21,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Nov 24, 2015·60 cites·36 claims
- 3796US9181223B22-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Nov 10, 2015·62 cites·29 claims
- 3896US9133183B2Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Sep 15, 2015·60 cites·32 claims
- 3995US12509443B2CSF-1R inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2025·Granted Dec 30, 2025·1 cites·21 claims
- 4095US9457019B2Methods for inhibiting tie-2 kinase useful in the treatment of cancerDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Oct 4, 2016·70 cites·42 claims
- 4195US9382228B2N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Jul 5, 2016·60 cites·43 claims
- 4295US9334267B2RAF inhibitor compoundsDECIPHERA PHARMACEUTICALS LLC·Filed 2013·Granted May 10, 2016·60 cites·17 claims
- 4395US7279576B2Anti-cancer medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2003·Granted Oct 9, 2007·67 cites·3 claims
- 4493US12226406B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Feb 18, 2025·0 cites·13 claims
- 4592US12318374B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Jun 3, 2025·0 cites·24 claims
- 4692US12318373B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Jun 3, 2025·0 cites·3 claims
- 4792US12295944B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted May 13, 2025·0 cites·1 claims
- 4892US12213968B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Feb 4, 2025·0 cites·18 claims
- 4992US12213967B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Feb 4, 2025·0 cites·11 claims
- 5092US2025387380A1Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
Showing the top 50 of 130 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when DECIPHERA PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →